Bayer Chief Executive Marijn Dekkers said Tuesday that the proposed agreement represented "a big landmark on the company's path to becoming a global leader in attracting the companies that produce over-the-counter drugs".
Bayer announced that this acquisition would make it a leader in North and South America when it comes to over-the-counter retail products.
This company already owns some main OTC brands such as painkillers Alev and Alka-Selcer and the vitamin One-a-day.